Case Study: Leveraging Expertise to Exceed Immunotherapy Customer Goals

Novella’s creative approach speeds site initiation and database build in this Phase I, multi-center study

A private biologics company needed a specialized oncology CRO to manage its Phase I, multi-center study to evaluate the safety and pharmacokinetic (PK) profile of an immunotherapeutic drug in subjects with advanced solid tumors. The senior director of clinical operations was searching for an oncology-experienced clinical trial partner that could support protocol design and accelerate the start-up process to meet a quick first-patient-in (FPI) milestone. Following a competitive review, the sponsor selected Novella Clinical based on our ability to deliver adaptive trial design, demonstrated oncology expertise, flexibility and understanding of nuanced immunotherapy drug trials.

Download CaseStudy_oncology